CRSP CRISPR Therapeutics AG

CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.

$66.88  -0.08 (-0.12%)
As of 06/27/2022 15:49:20 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Switzerland
Country of incorporation:  Switzerland
IPO date:  10/19/2016
Outstanding shares:  77,457,081
Average volume:  2,735,549
Market cap:   $5,046,328,827
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BDHF4K6

---

Valuation   (See tab for details)

---

PE ratio:   16.64
PB ratio:   2.31
PS ratio:   5.52
Return on equity:   13.88%
Net income %:   34.07%